Payment overview · 2025
General Payments
$62.17
3 reported records · 1 companies
Healthcare provider profile · identity verified
Ashok Devidas Sawlani, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CHICAGO, IL · NPI 1518044387
Verified facts
What the public records show
CMS Open Payments records show Ashok Devidas Sawlani, M.D. received $62.17 in general payments during 2025 across 3 reported records.
Novartis Pharmaceuticals Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Entresto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $62.17 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $62.17 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $62.17 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1183 | 253 |
| Amlodipine Besylate | Amlodipine Besylate | 851 | 186 |
| Pantoprazole Sodium | Pantoprazole Sodium | 628 | 131 |
| Furosemide | Furosemide | 613 | 138 |
| Potassium Chloride | Potassium Chloride | 612 | 115 |
| Levothyroxine Sodium | Levothyroxine Sodium | 573 | 104 |
| Gabapentin | Gabapentin | 518 | 96 |
| Eliquis | Apixaban | 415 | 85 |
| Metoprolol Succinate | Metoprolol Succinate | 367 | 94 |
| Tamsulosin Hcl | Tamsulosin Hcl | 331 | 72 |
| Losartan Potassium | Losartan Potassium | 322 | 82 |
| Memantine Hcl | Memantine Hcl | 317 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 317 | 70 |
| Quetiapine Fumarate | Quetiapine Fumarate | 288 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 253 | 48 |
| Lisinopril | Lisinopril | 241 | 56 |
| Sertraline Hcl | Sertraline Hcl | 230 | 29 |
| Simvastatin | Simvastatin | 229 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 228 | 37 |
| Allopurinol | Allopurinol | 214 | 31 |
| Donepezil Hcl | Donepezil Hcl | 193 | 31 |
| Metformin Hcl | Metformin Hcl | 186 | 57 |
| Jantoven | Warfarin Sodium | 185 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 177 | 22 |
| Carvedilol | Carvedilol | 167 | 43 |
| Mirtazapine | Mirtazapine | 154 | 25 |
| Omeprazole | Omeprazole | 154 | 36 |
| Bumetanide | Bumetanide | 152 | 22 |
| Tramadol Hcl | Tramadol Hcl | 139 | 34 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 137 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 117 | 36 |
| Lamotrigine | Lamotrigine | 115 | suppressed |
| Alprazolam | Alprazolam | 111 | 28 |
| Famotidine | Famotidine | 96 | 20 |
| Glipizide | Glipizide | 95 | 21 |
| Montelukast Sodium | Montelukast Sodium | 91 | 15 |
| Spironolactone | Spironolactone | 89 | 18 |
| Prednisone | Prednisone | 88 | 30 |
| Enalapril Maleate | Enalapril Maleate | 84 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 81 | 41 |
| Midodrine Hcl | Midodrine Hcl | 76 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 75 | 27 |
| Olanzapine | Olanzapine | 75 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 73 | 19 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 30 |
| Warfarin Sodium | Warfarin Sodium | 71 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 69 | suppressed |
| Baclofen | Baclofen | 68 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 68 | 44 |
| Levetiracetam | Levetiracetam | 66 | 16 |
| Glipizide Er | Glipizide | 65 | 20 |
| Entacapone | Entacapone | 64 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 62 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 61 | 26 |
| Bethanechol Chloride | Bethanechol Chloride | 60 | 15 |
| Azithromycin | Azithromycin | 59 | 41 |
| Breo Ellipta | Fluticasone/Vilanterol | 58 | 15 |
| Finasteride | Finasteride | 58 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 57 | 21 |
| Atenolol | Atenolol | 56 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 55 | 17 |
| Buspirone Hcl | Buspirone Hcl | 55 | suppressed |
| Jardiance | Empagliflozin | 55 | 20 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 55 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 53 | 39 |
| Divalproex Sodium | Divalproex Sodium | 49 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 48 | suppressed |
| Ibuprofen | Ibuprofen | 47 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | suppressed |
| Latanoprost | Latanoprost | 44 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 42 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 42 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 39 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 39 | 25 |
| Labetalol Hcl | Labetalol Hcl | 39 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 36 | suppressed |
| Lactulose | Lactulose | 36 | suppressed |
| Levemir Flexpen | Insulin Detemir | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 36 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Ezetimibe | Ezetimibe | 35 | suppressed |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 35 | 15 |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Lorazepam | Lorazepam | 33 | 13 |
| Meloxicam | Meloxicam | 33 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | 11 |
| Januvia | Sitagliptin Phosphate | 31 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Rytary | Carbidopa/Levodopa | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Rivastigmine | Rivastigmine | 29 | suppressed |
| Cefdinir | Cefdinir | 28 | 18 |
| Digoxin | Digoxin | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Ramipril | Ramipril | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 25 | 19 |
| Cephalexin | Cephalexin | 25 | 22 |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 17 |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 21 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 20 | 20 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 19 | suppressed |
| Valproic Acid | Valproic Acid | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | 13 |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Scopolamine | Scopolamine | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Acarbose | Acarbose | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Captopril | Captopril | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Np Thyroid | Thyroid,pork | 14 | suppressed |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Thyroid | Thyroid,pork | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Zonisamide | Zonisamide | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Niva Thyroid | Thyroid,pork | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $62.17 · 3 records | Novartis Pharmaceuticals Corporation | LEQVIO | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novartis Pharmaceuticals Corporation?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error